SBFM
Sunshine Biopharma Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.24
+9.02%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.22
From 52W high−98.84%
Volume1.27M
Market cap$1.04M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$0.22
From 52W high
−98.84%
Volume
1.27M
Market cap
$1.04M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.3x
P/E (TTM)
—
RSI (14)
27.6
MomentumView details →
1D Return
+9.02%
YTD Return
−98.08%
SummaryUpdated Jun 1, 2026
Sunshine Biopharma, Inc. (NASDAQ:SBFM) is a Canadian pharmaceutical and nutritional supplement company founded and headquartered in Pointe-Claire, Canada. The company went public on February 15, 2022, representing a relatively recent entrant to the public markets. Sunshine Biopharma operates as a dual-focus enterprise, combining early-stage anticancer drug development with an established nutritional supplement business that generates the majority of its current revenue.
Similar companies
Latest newsMore news →
Sunshine Biopharma Inc. announced the pricing of a public offering expected to generate approximately $6.0 million in gross proceeds, comprising 10,909,083 common or pre-funded units with two Series D warrants per unit.12d agoSunshine Biopharma Inc. advanced its lead Coronavirus drug candidate into IND-enabling studies.34d ago